Article
Gut-related Immune Activation in Parkinson’s Disease with Asian <i>LRRK2</i> Risk Variants: Associations with Systemic Inflammation and Clinical Severity
2026-07-14
Abstract excerpt
<h4>ABSTRACT</h4> LRRK2 is implicated in Parkinson’s disease (PD) microbiome–gut–brain axis. We compared plasma lipopolysaccharide-binding protein (LBP) and soluble CD14 (sCD14), markers of gut permeability and endotoxin exposure, in PD patients with/without LRRK2 p.G2385R and/or p.R1628P, and controls, and examined their associations with systemic inflammation and clinical severity. Neither marker differed betw...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- effbbc74-fac9-5a5a-9a16-5e95c31caedf
- DOI
- 10.64898/2026.07.10.26357757
